175 related articles for article (PubMed ID: 15772145)
1. Patient adherence to prescribed antimicrobial drug dosing regimens.
Vrijens B; Urquhart J
J Antimicrob Chemother; 2005 May; 55(5):616-27. PubMed ID: 15772145
[TBL] [Abstract][Full Text] [Related]
2. The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analyses.
Vrijens B; Gross R; Urquhart J
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):225-7. PubMed ID: 15733218
[TBL] [Abstract][Full Text] [Related]
3. Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among physicians and patients.
Gallant JE; Block DS
J Int Assoc Physicians AIDS Care; 1998 May; 4(5):32-5. PubMed ID: 11365186
[TBL] [Abstract][Full Text] [Related]
4. Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models.
Vrijens B; Tousset E; Rode R; Bertz R; Mayer S; Urquhart J
J Clin Pharmacol; 2005 Apr; 45(4):461-7. PubMed ID: 15778427
[TBL] [Abstract][Full Text] [Related]
5. Once-daily dosing of nevirapine in HAART.
Clotet B
J Antimicrob Chemother; 2008 Jan; 61(1):13-6. PubMed ID: 18006524
[TBL] [Abstract][Full Text] [Related]
6. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
7. Impact of once- and twice-daily dosing regimens on adherence and overall safety.
Hawkins T
AIDS Read; 2004 Jun; 14(6):320-2, 324, 329-31, 334-6. PubMed ID: 15243968
[TBL] [Abstract][Full Text] [Related]
8. Medication adherence in patients with HIV infection: a comparison of two measurement methods.
Melbourne KM; Geletko SM; Brown SL; Willey-Lessne C; Chase S; Fisher A
AIDS Read; 1999 Aug; 9(5):329-38. PubMed ID: 12737122
[TBL] [Abstract][Full Text] [Related]
9. Variable adherence to prescribed dosing regimens for protease inhibitors: scope and outcomes.
Blaschke TF
Curr Opin HIV AIDS; 2008 Nov; 3(6):603-7. PubMed ID: 19373030
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics.
Osterberg LG; Urquhart J; Blaschke TF
Clin Pharmacol Ther; 2010 Oct; 88(4):457-9. PubMed ID: 20856243
[TBL] [Abstract][Full Text] [Related]
12. Obstacles to treatment success.
Cadman J
GMHC Treat Issues; 1998 Oct; 12(10):8-10. PubMed ID: 11365904
[TBL] [Abstract][Full Text] [Related]
13. Ascertaining how much compliance is enough with outpatient antibiotic regimens.
Urquhart J
Postgrad Med J; 1992; 68 Suppl 3():S49-58; discussion S59. PubMed ID: 1287619
[TBL] [Abstract][Full Text] [Related]
14. Predicting and monitoring antiretroviral adherence.
Gross R
LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
[TBL] [Abstract][Full Text] [Related]
15. Making the most of once-daily anti-HIV therapy.
Cox S
Posit Aware; 1998; 9(6):43. PubMed ID: 11366482
[TBL] [Abstract][Full Text] [Related]
16. Fixed-dose combinations improve medication compliance: a meta-analysis.
Bangalore S; Kamalakkannan G; Parkar S; Messerli FH
Am J Med; 2007 Aug; 120(8):713-9. PubMed ID: 17679131
[TBL] [Abstract][Full Text] [Related]
17. How to measure or mend adherence a big unknown.
AIDS Alert; 1998 Feb; 13(2):20-1. PubMed ID: 11365037
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis.
Tourret J; Tostivint I; Tézenas Du Montcel S; Karie S; Launay-Vacher V; Vigneau C; Bessette C; Deray G; Bagnis CI
Clin Infect Dis; 2007 Sep; 45(6):779-84. PubMed ID: 17712764
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
20. Managing TB in the 21st century: existing and novel drug therapies.
Guy ES; Mallampalli A
Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
